SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-011404
Filing Date
2024-03-27
Accepted
2024-03-27 08:40:51
Documents
115
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3632161
2 ex19-1.htm EX-19.1 95931
3 ex19-2.htm EX-19.2 7208
4 ex21-1.htm EX-21.1 2765
5 ex23-1.htm EX-23.1 3928
6 ex23-2.htm EX-23.2 4308
7 ex31-1.htm EX-31.1 18476
8 ex31-2.htm EX-31.2 18832
9 ex32-1.htm EX-32.1 11089
10 form10-k_1.jpg GRAPHIC 9587
11 form10-k_2.jpg GRAPHIC 28298
12 form10-k_3.jpg GRAPHIC 221718
13 form10-k_4.jpg GRAPHIC 35100
14 image_006.jpg GRAPHIC 1075
15 image_007.jpg GRAPHIC 1118
16 image_008.jpg GRAPHIC 1112
17 image_009.jpg GRAPHIC 1065
18 image_010.jpg GRAPHIC 1056
19 image_014.jpg GRAPHIC 1460
20 image_015.gif GRAPHIC 2879
21 image_015.jpg GRAPHIC 4089
22 image_016.jpg GRAPHIC 4368
23 image_017.jpg GRAPHIC 3918
24 image_018.jpg GRAPHIC 4903
25 image_019.jpg GRAPHIC 4752
26 image_020.jpg GRAPHIC 33121
27 evfmtsr_001.jpg GRAPHIC 128369
28 netloss_001.jpg GRAPHIC 143246
  Complete submission text file 0001493152-24-011404.txt   16053253

Data Files

Seq Description Document Type Size
29 XBRL SCHEMA FILE evfm-20231231.xsd EX-101.SCH 94208
30 XBRL CALCULATION FILE evfm-20231231_cal.xml EX-101.CAL 88700
31 XBRL DEFINITION FILE evfm-20231231_def.xml EX-101.DEF 427755
32 XBRL LABEL FILE evfm-20231231_lab.xml EX-101.LAB 750850
33 XBRL PRESENTATION FILE evfm-20231231_pre.xml EX-101.PRE 579699
119 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2353694
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36754 | Film No.: 24785946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)